- Report
- November 2018
- 17 Pages
Spain
From €2878EUR$2,995USD£2,470GBP
- Report
- November 2018
- 17 Pages
Italy
From €2878EUR$2,995USD£2,470GBP
- Report
- November 2018
- 17 Pages
France
From €2878EUR$2,995USD£2,470GBP
- Report
- November 2018
- 17 Pages
United Kingdom
From €2878EUR$2,995USD£2,470GBP
- Report
- November 2018
- 17 Pages
Brazil
From €2878EUR$2,995USD£2,470GBP
- Report
- November 2018
- 17 Pages
Mexico
From €2878EUR$2,995USD£2,470GBP
- Report
- November 2018
- 17 Pages
Japan
From €2878EUR$2,995USD£2,470GBP
Neurovascular embolization is a minimally invasive surgical procedure used to treat a variety of conditions, including aneurysms, arteriovenous malformations, and tumors. It involves the insertion of a catheter into an artery, usually in the groin, and the injection of a substance, such as a coil, glue, or particles, into the affected area. This substance blocks the blood flow to the affected area, reducing the risk of bleeding and other complications. The procedure is typically performed under local anesthesia and can be done in an outpatient setting.
The neurovascular embolization procedure market is driven by the increasing prevalence of neurological disorders, technological advancements, and the growing demand for minimally invasive procedures. The market is further supported by the increasing number of hospitals and healthcare centers, as well as the availability of skilled professionals.
Some companies in the neurovascular embolization procedure market include Medtronic, Stryker, Boston Scientific, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, and Cook Medical. Show Less Read more